These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18346292)

  • 1. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.
    Vieta E; Manuel Goikolea J; Martínez-Arán A; Comes M; Verger K; Masramon X; Sanchez-Moreno J; Colom F
    J Clin Psychiatry; 2006 Mar; 67(3):473-7. PubMed ID: 16649836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
    J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
    Kemp DE; Gao K; Fein EB; Chan PK; Conroy C; Obral S; Ganocy SJ; Calabrese JR
    Bipolar Disord; 2012 Nov; 14(7):780-9. PubMed ID: 23107222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Kowatch RA; Emslie GJ; Findling RL; Wilens TE; McCague K; D'Souza J; Wamil A; Lehman RB; Berv D; Linden D
    Am J Psychiatry; 2006 Jul; 163(7):1179-86. PubMed ID: 16816222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
    Berk M; Ng F; Wang WV; Calabrese JR; Mitchell PB; Malhi GS; Tohen M
    J Affect Disord; 2008 Feb; 106(1-2):153-8. PubMed ID: 17655936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.